A retrospective Expanded Access (EA) program of Clofazimine to treat Nontuberculous mycobacteria
Latest Information Update: 22 Jul 2022
At a glance
- Drugs Clofazimine (Primary)
- Indications Nontuberculous mycobacterium infections
- Focus Therapeutic Use
Most Recent Events
- 22 Jul 2022 New trial record